Pharma Industry News

A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.

statnews.com - Matthew Herper - Anthropic releases Claude Science, a product aimed at researchers, the pharma industry
Anthropic releases Claude Science, a product aimed at researchers, the pharma industry
STAT

SAN FRANCISCO — Anthropic, the artificial intelligence firm, on Tuesday announced the availability of Claude Science, an application that optimizes the company's large language model for use in scientific laboratories and, especially, within…

globenewswire.com - Zealand Pharma - Zealand Pharma major shareholder announcement: The Capital Group Companies, Inc.
Zealand Pharma major shareholder announcement: The Capital Group Companies, Inc.
GlobeNewswire

Company announcement No. 29 / 2026 Zealand Pharma major shareholder announcement: The Capital Group Companies, Inc. Copenhagen, Denmark, June 30, 2026 – Zealand Pharma A/S ('the Company' or “Zealand Pharma”) (Nasdaq: ZEAL)…

globenewswire.com - Zealand Pharma - Total number of shares and voting rights in Zealand Pharma as of June 30, 2026
Total number of shares and voting rights in Zealand Pharma as of June 30, 2026
GlobeNewswire

Company announcement – No. 30 / 2026 Total number of shares and voting rights in Zealand Pharma as of June 30, 2026 Copenhagen, Denmark, June 30, 2026 – Zealand Pharma A/S (“Zealand Pharma” or 'the Company') (Nasdaq:…

marketwatch.com - Liminatus Pharma Amends InnocsAI Merger Deal, Sets July 2 Closing
Liminatus Pharma Amends InnocsAI Merger Deal, Sets July 2 Closing
MarketWatch

Liminatus Pharma said Tuesday it amended its merger agreement with InnocsAI LLC to allow the deal to close before shareholder approval, with closing now expected July 2. InnocsAI equity holders will receive Liminatus common stock and non-voting…

yahoo.com - Laiba Immad - Why Ascentage Pharma Group Internat (AAPG) Is Gaining Attention in Cancer Drug Development
Why Ascentage Pharma Group Internat (AAPG) Is Gaining Attention in Cancer Drug Development
Yahoo!

We recently compiled a list of the 10 Best Biotech Stocks to Buy According to Analysts. Ascentage Pharma Group Internat (NASDAQ:AAPG) is one of the best biotech stocks on this list. TheFly reported on June 15 that Oppenheimer initiated coverage of…

globenewswire.com - Nxera Pharma - Nxera Pharma to Receive US$10 Million Milestone Payment from AbbVie under Collaboration Targeting Neurological Diseases
Nxera Pharma to Receive US$10 Million Milestone Payment from AbbVie under Collaboration Targeting Neurological Diseases
GlobeNewswire

This marks the fourth R&D milestone achieved under the collaboration, and the second in 2026, reflecting the steady progress of development under the collaboration Under the terms of the agreement, Nxera is eligible to receive up to US$1.2 billion…

republicworld.com - Asian News International - Petrochemical Import Duty Waiver Extended To July 15 To Aid Plastics, Pharma, Textiles
Petrochemical Import Duty Waiver Extended To July 15 To Aid Plastics, Pharma, Textiles
Republic World

New Delhi: The central government on Tuesday extended full customs duty exemption on critical petrochemical products, given in view of the conflict in West Asia, till July 15. A Finance Ministry release said that the Government had earlier provided…

fool.com - Cory Renauer - Is UroGen Pharma a Stock to Sell After Its Chief Medical Officer Let Go of 10,000 Shares?
Is UroGen Pharma a Stock to Sell After Its Chief Medical Officer Let Go of 10,000 Shares?
The Motley Fool

Mark Schoenberg, Chief Medical Officer of UroGen Pharma Ltd. (URGN +2.02%), reported the sale of 10,000 shares of common stock in an open-market transaction on June 22, 2026, according to a SEC Form 4 filing. MetricValueShares sold…

taipeitimes.com - 台北時報 - Chugai Pharma Taiwan Wins Asia Responsible Enterprise Awards for Fifth Consecutive Year
Chugai Pharma Taiwan Wins Asia Responsible Enterprise Awards for Fifth Consecutive Year
Taipei Times

Chugai Pharma Taiwan (CPT) has once again achieved a landmark milestone in sustainability, earning recognition at one of Asia's most prestigious sustainability honors — the Asia Responsible Enterprise Awards (AREA). This year's awards…

thehindubusinessline.com - Aurobindo Pharma completes acquisition of US-based Lannett Company
Aurobindo Pharma completes acquisition of US-based Lannett Company
BusinessLine

, an arm of Aurobindo Pharma, completed the previously announced acquisition of Lannett Company, Inc., USA from Lannett Seller Holdco, Inc. On June 18, 2026, Aurobindo received approval from the US Federal Trade Commission for the acquisition.

wwd.com - Kathryn Hopkins - What the Future of Beauty Holds, According to Five Top Scientists
What the Future of Beauty Holds, According to Five Top Scientists
WWD

While chemistry dominated beauty for 100 years, its future may lie in biology. Personalization, holistic approaches and consumer savviness are also expected to define the landscape. “Engineering ingredients for specific biological outcomes…

businessinsider.com - Samuel O'Brient - Apollo's top economist warns of a painful market repricing as return on AI investment slows
Apollo's top economist warns of a painful market repricing as return on AI investment slows
Business Insider

Uneven returns on AI investment could be a wakeup call for the red-hot stock market, a top economist says. US equities are roaring, with unrelenting tech bullishness putting the the Nasdaq 100 on track for its best quarter in years. Yet, Torsten…

mirror.co.uk - Steven Smith - New UK antibiotics alert as 'defect' notice issued
New UK antibiotics alert as 'defect' notice issued
Daily Mirror

A new warning has been issued for a type of penicillin used across the UK. The Medicines and Healthcare products Regulatory Agency (MHRA) announced in a new 'Class 4 Medicines Defect Notification' that Brancaster Pharma Limited had notified it that…

seekingalpha.com - Edmund Ingham - Abivax: Latest Obefazimod Data Eases Safety Fears, Brings M&A Back Into Play (NASDAQ:ABVX)
Abivax: Latest Obefazimod Data Eases Safety Fears, Brings M&A Back Into Play (NASDAQ:ABVX)
Seeking Alpha

ABIVAX Société Anonyme surged >35% on positive Phase 3 data for obefazimod in ulcerative colitis, reinforcing its differentiated, multi-pathway mechanism and best-in-class profile. Recent safety data alleviated cancer concerns…

prweb.com - Kairos Meridian LLC - Kairos Meridian Launches an Independent, Shorter Path From Problem to Impact
Kairos Meridian Launches an Independent, Shorter Path From Problem to Impact
PRWeb

Most commercial programs are still measured for activity rather than impact. Brand teams are held to tangible results while being pressured to do more with less. Too often they are left choosing between large agencies that add unnecessary…

Receive a Daily briefing on Pharma Industry News

Get Started